Eli Lilly Pulls 'Ineffective' Sepsis Drug Xigris
Eli Lilly & Co. will withdraw its sepsis-treatment drug Xigris from the market after clinical trials found no benefit to using it, the pharmaceutical giant announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article